ArticleVaccine2014

Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response.

Michael Maynard-Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.